AngioDynamics, Inc. (ANGO) Posts Q4 GAAP Loss of 3c/Share; Guides FY12
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.67 +1.62%
Revenue Growth %: +6.3%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.3%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AngioDynamics, Inc. (NASDAQ: ANGO) reported Q4 GAAP loss of $0.03, which may not compare to the analyst estimate of $0.10. Revenue for the quarter came in at $56.4 million versus the consensus estimate of $56.96 million.
Sees FY2012 EPS of $0.41-$0.49, versus the consensus of $0.48. Sees FY2012 revenue of $217-$225 million, versus the consensus of $216.43 million.
Sees FY2012 EPS of $0.41-$0.49, versus the consensus of $0.48. Sees FY2012 revenue of $217-$225 million, versus the consensus of $216.43 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Kroger outlines AI strategy at GroceryShop 2026 conference
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
